COVID-19 rapid guideline: children and young people who are immunocompromised, NICE NG174 (Updated 21st May)

Immunosuppressant medicines have been added to recommendation 1.4 because these should be reviewed if a child or young person may have COVID-19 or there are medical concerns. Recommendation 1.7 has been aligned with UK government guidance for young people on shielding.
Source: Current Awareness Service for Health (CASH) - Category: Consumer Health News Source Type: news

Related Links:

Publication date: Available online 23 May 2020Source: American Heart JournalAuthor(s): Nabil Braiteh, Wajeeh ur Rehman, Md Alom, Vincent Skovira, Nour Breiteh, Ibraheem Rehman, Alon Yarkoni, Hisham Kahsou, Afzal Rehman
Source: American Heart Journal - Category: Cardiology Source Type: research
Publication date: Available online 23 May 2020Source: Trends in Anaesthesia and Critical CareAuthor(s): Edoardo Mannucci, Giovanni Antonio Silverii, Matteo Monami
Source: Trends in Anaesthesia and Critical Care - Category: Anesthesiology Source Type: research
Publication date: May–June 2020Source: Revista Española de Medicina Nuclear e Imagen Molecular (English Edition), Volume 39, Issue 3Author(s): Joan Castell Conesa
Source: Revista Espanola de Medicina Nuclear e Imagen Molecular - Category: Nuclear Medicine Source Type: research
This article aims to provide recommendations and relevant information for rhinologists, based on the limited amount of (anecdotal) data, to guarantee high-quality patient care and adequate levels of infection prevention in the rhinology clinic. PMID: 32441710 [PubMed - as supplied by publisher]
Source: Rhinology - Category: ENT & OMF Tags: Rhinology Source Type: research
Authors: Garzotto F, Ceresola E, Panagiotakopoulou S, Spina G, Menotto F, Benozzi M, Casarotto M, Lanera C, Bonavina MG, Gregori D, Meneghesso G, Opocher G Abstract To predict the spread of coronavirus disease globally and consequently prepare the hospital facilities with the required technology is a challenge. The availability of essential medical equipment to support patients affected by Covid-19 is globally limited. AREAS COVERED: This perspective gives a technical view of the pandemic focusing on the main actions taken by regulatory agencies to cope with the shortage of devices. The risk/benefit assessment ...
Source: Expert Review of Medical Devices - Category: Medical Devices Tags: Expert Rev Med Devices Source Type: research
Authors: Abedini R, Ghandi N, Lajevardi V, Ghiasi M, Nasimi M PMID: 32436754 [PubMed - as supplied by publisher]
Source: Journal of Dermatological Treatment - Category: Dermatology Tags: J Dermatolog Treat Source Type: research
Authors: Espiner E, Poole G, Mullaney TG, Hoh SM PMID: 32438386 [PubMed - in process]
Source: New Zealand Medical Journal - Category: General Medicine Tags: N Z Med J Source Type: research
Authors: Ameratunga R, Lehnert K, Leung E, Comoletti D, Snell R, Woon ST, Abbott W, Mears E, Steele R, McKee J, Muscroft-Taylor A, Ameratunga S, Medlicott N, Das S, Rolleston W, Quiñones-Mateu M, Petousis-Harris H, Jordan A Abstract COVID-19 is a new zoonotic disease caused by the SARS-CoV-2 virus. Since its emergence in Wuhan City, China, the virus has rapidly spread across the globe causing calamitous health, economic and societal consequences. It causes disproportionately severe disease in the elderly and those with co-morbidities, such as hypertension and diabetes. There is currently no proven treatment ...
Source: New Zealand Medical Journal - Category: General Medicine Tags: N Z Med J Source Type: research
This article focuses on identifying practical issues and providing some solutions. PMID: 32438382 [PubMed - in process]
Source: New Zealand Medical Journal - Category: General Medicine Tags: N Z Med J Source Type: research
Publication date: Available online 23 May 2020Source: Journal of Microbiology, Immunology and InfectionAuthor(s): Chih-Cheng Lai, Cheng-Yi Wang, Po-Ren Hsueh
Source: Journal of Microbiology, Immunology and Infection - Category: Microbiology Source Type: research
More News: Children | COVID-19 | Government | Health | National Institute for Health and Clinical Excelle | Wuhan Coronavirus